Adopting Virtual Approaches in Oncology Trials: Patient-centric trial delivery during COVID-19 and beyond


Sponsored Content

Adoption of remote and virtual trial tools is helping to ensure the safety of cancer patients during the pandemic. IQVIA shares how incorporating patient-centric approaches in future oncology trials can increase patient access and engagement. Live: Tuesday, Jun. 9, 2020 at 11am EDT On demand available after airing until Jun. 9, 2021. Register free

Register free:

Event Overview:

Cancer patients are among the most vulnerable during the COVID-19 pandemic. Sponsors and investigators managing oncology clinical trials have quickly embraced remote and virtual tools to keep patients safe and keep trials moving forward.   

Suddenly, what was ‘risky’ is now risk mitigation. And patients who traveled to research centers for trial visits are now seeing the trial come to them, which is a good omen for improving patients’ access to future oncology trials.  

Join our webinar and learn how to incorporate virtual approaches into the design and delivery of oncology trials – to lower overall study risks and increase patient engagement.

Our experts will share:

  • Lessons learned from adapting ongoing oncology trials to the COVID-19 era

  • Criteria to identify which trials are suitable for virtual/hybrid, and which are not

  • Innovative and flexible approaches that improve the patient experience

Speakers: Cristina Oliva, MD, Vice President, Head of Oncology Center of Excellence, IQVIA

Cindy Venendaal, MPH, PhD, Vice President, Clinical Operations, IQVIA Biotech

Robin Douglas, MA, CCRC, Senior Director, Head of Operations, Virtual Trials, IQVIA

Time and date: Tuesday, Jun. 9, 2020 at 11am EDT

On demand available after airing until Jun. 9, 2021.

Sponsor: IQVIA 

Register free:

Related Content
© 2024 MJH Life Sciences

All rights reserved.